Ascendis Pharma A-S
Price & Volume
Stats
See more52W Range | $118.03-$223.18 |
Market Cap | $12.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $646.5M |
Revenue Growth (YoY) | 269.4% |
Gross Profit (12 Mos) | $561.2M |
Diluted EPS | -$4.40 |
News
See moreYahoo Finance • 8 days ago
Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics
Yahoo Finance • 11 days ago
Liberty All-Star® Growth Fund, Inc. October 2025 Monthly Update
Yahoo Finance • 13 days ago
Ascendis Pharma GAAP EPS of - €1.00, revenue of €143.1M
Yahoo Finance • 13 days ago
Ascendis Pharma Reports Third Quarter 2025 Financial Results
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,017 |
